iHuman Inc.
IH · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.03 | 0.02 | -0.00 | 0.14 |
| FCF Yield | 39.53% | 70.58% | 651.83% | 3.13% |
| EV / EBITDA | -11.44 | -5.68 | -6.94 | 13.20 |
| Quality | ||||
| ROIC | 6.57% | 14.85% | 11.86% | -8.41% |
| Gross Margin | 69.42% | 70.84% | 70.13% | 69.93% |
| Cash Conversion Ratio | 0.59 | 0.95 | 1.72 | -1.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.19% | 2.53% | 22.82% | 62.87% |
| Free Cash Flow Growth | -69.15% | -86.71% | 20,912.06% | -97.14% |
| Safety | ||||
| Net Debt / EBITDA | -12.95 | -7.05 | -8.50 | 17.17 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 12.01 | 17.97 | 15.39 | 10.13 |
| Cash Conversion Cycle | 12.66 | 15.55 | 24.03 | 19.60 |